Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction

DOI: 10.1080/2162402X.2016.1202390

Keywords: Checkpoint inhibition, immunotherapy, melanoma, PD-L1, TRAIL

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text